Target intelligence / Profile preview

Microtubule-associated proteins 1A/1B light chain 3B (LC3B)

Target
LC3B
Molecular classification
Autophagy-related protein, Ubiquitin-like protein
01

Overview

Microtubule-associated proteins 1A/1B light chain 3B (LC3B) is a central protein in the macroautophagy pathway, essential for the formation, maturation, and cargo selection of autophagosomes (UniProt P60709). It undergoes a C-terminal cleavage by ATG4 to form the cytosolic LC3-I, which is subsequently conjugated to phosphatidylethanolamine to form LC3-II, the membrane-bound form used as a definitive hallmark of autophagic activity (PubMed: 23280503). LC3B acts as an adapter protein, interacting with LIR-containing cargo receptors like p62 to facilitate the selective degradation of cellular components such as damaged organelles or protein aggregates (PubMed: 28445460). In oncology, LC3-mediated autophagy can promote tumor survival under metabolic stress, making it a target for inhibitors like hydroxychloroquine which block the degradation of LC3-II (PubMed: 30229034). Conversely, enhancing LC3-dependent clearance is a therapeutic strategy for neurodegenerative diseases characterized by protein aggregation, such as Alzheimer's and Parkinson's (PubMed: 31160674). Current drug development also explores LC3-targeting chimeras (AUTACs) that leverage the LC3 machinery to direct specific pathogenic proteins for autophagic degradation (PubMed: 31806907).

Other names
MAP1LC3BLC3Autophagy-related protein LC3BMicrotubule-associated protein 1 light chain 3 betaATG8F
02

Mechanism of action

Modulation of autophagic flux through the inhibition of autophagosome-lysosome fusion or the induction of autophagosome formation and cargo recruitment.

03

Biological functions

AutophagyAutophagosome formationCargo recognitionMitophagyProtein degradationXenophagy
04

Disease associations

CancerNeurodegenerative diseaseInfectionInflammationCardiovascular disease
05

Safety considerations

Off-target effects of systemic autophagy modulationPotential for tumor promotion in established cancersLysosomal storage-like toxicityImpairment of immune response to certain pathogens
06

Interacting drugs

Chloroquine

6 more in the full profile.

07

Biomarkers

LC3-II/LC3-I ratioLC3 puncta formationp62/SQSTM1 levelsAutophagic flux index

Beyond the preview

Go deeper on Microtubule-associated proteins 1A/1B light chain 3B (LC3B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule-associated proteins 1A/1B light chain 3B (LC3B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call